查看購物車
  • English
  • Japanese
  • Korean
2025-2029年全球人工智慧（AI）在製藥和生物技術領域的應用
市場調查報告書
商品編碼
1915647

2025-2029年全球人工智慧（AI）在製藥和生物技術領域的應用

Global AI In Pharma And Biotech Market 2025-2029
出版日期: | 出版商: TechNavio | 英文 310 Pages | 訂單完成後即時交付

價格
簡介目錄

全球醫藥和生物技術領域的人工智慧（AI）市場預計在2024年至2029年的預測期內將以20.0%的複合年成長率成長，達到36.324億美元。本報告對全球醫藥和生物技術領域的人工智慧市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約25家公司的供應商分析。

本報告對當前市場格局、最新趨勢和促進因素以及整體市場環境進行了最新分析，其促進因素包括：克服研發效率下降和成本上升的需求、生物醫學數據的指數級成長和高性能計算的普及、投資增加、戰略聯盟以及最佳實踐的檢驗。

本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告提供歷史數據和預測數據。

市場覆蓋範圍
基準年 2025
目標期 2029
預測期 2025-2029
成長勢頭 加速度
同比 18.2%
複合年成長率 20%
增量 36.324億美元

該研究指出，透過可擴展的 AI 驅動研發平台實現發現的產業化，是未來幾年推動 AI 在全球製藥和生物技術市場成長的關鍵因素之一。 AI 驅動的生物標記發現、精準醫療的擴展、AI 與真實世界數據 (RWE) 的更深入融合以及臨床試驗的現代化，預計將在市場中產生巨大的需求。

目錄

第1章執行摘要

第2章 Technavio 分析

  • 價格、生命週期、顧客購買籃、採用率和購買標準分析
  • 投入與差異化因素的重要性
  • 混淆來源
  • 促進因素和挑戰的影響

第3章 市場情勢

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場區隔分析
  • 2024年市場規模
  • 2024-2029年市場展望

第5章 市場規模表現

  • 2019-2023年全球人工智慧（AI）在製藥和生物技術領域的市場
  • 類型細分市場分析 2019-2023
  • 2019-2023年技術細分市場分析
  • 應用細分市場分析 2019-2023
  • 2019-2023年區域細分市場分析
  • 2019-2023年國家細分市場分析

第6章五力分析

  • 五力分析概述
  • 買方的議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

7. 按類型分類的市場細分

  • 比較：按類型
  • 低分子化合物
  • 大分子
  • 疫苗
  • 細胞和基因治療
  • 按類型分類的市場機會

8. 按技術分類的市場細分

  • 比較：按技術
  • 機器學習
  • 深度學習
  • 自然語言處理（NLP）
  • 電腦視覺
  • 人工智慧世代
  • 按技術分類的市場機遇

第9章 按應用進行市場細分

  • 比較：透過應用
  • 藥物發現
  • 非臨床和臨床試驗
  • 監管合規與藥物監測
  • 其他
  • 按應用分類的市場機會

第10章 客戶情況

第11章 區域情勢

  • 區域細分
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 荷蘭
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 土耳其
    • 以色列
  • 各區域的市場機遇

第12章：促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第13章 競爭格局

  • 概述
  • 競爭格局
  • 令人困惑的局面
  • 產業風險

第14章 競爭分析

  • 公司簡介
  • 企業排名指數
  • 公司市場定位
  • Aria Intelligent Solutions
  • Auransa Inc.
  • BenevolentAI
  • BioAge Labs Inc.
  • Cloud Pharmaceuticals Inc.
  • Exscientia plc
  • Insilico Medicine
  • Owkin Inc.
  • PathAI Inc.
  • Recursion Pharmaceuticals Inc.
  • Schrodinger Inc.
  • Turbine Ltd.
  • Valo Health
  • Verge Analytics Inc.
  • Shenzhen Jingtai Technology Co.Ltd

第15章附錄

簡介目錄
Product Code: IRTNTR81042

The global AI in pharma and biotech market is forecasted to grow by USD 3632.4 mn during 2024-2029, accelerating at a CAGR of 20.0% during the forecast period. The report on the global AI in pharma and biotech market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative to overcome declining research and development productivity and escalating costs, exponential growth of biomedical data and availability of high-performance computing, increasing investment, strategic collaborations, and validating success stories.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 202518.2%
CAGR20%
Incremental Value$3632.4 mn

Technavio's global AI in pharma and biotech market is segmented as below:

By Type

  • Small molecules
  • Large molecules
  • Vaccines
  • Cell and gene therapies

By Technology

  • Machine learning
  • Deep learning
  • NLP
  • Computer vision
  • Generative AI

By Application

  • Drug discovery
  • Preclinical and clinical trials
  • Regulatory compliance and pharmacovigilance
  • Others

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • The Netherlands
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • UAE
    • South Africa
    • Turkey
  • Rest of World (ROW)

This study identifies the industrialization of discovery through scalable, ai-powered research and development platforms as one of the prime reasons driving the global AI in pharma and biotech market growth during the next few years. Also, ai-driven biomarker discovery and scaling of precision medicine and increasing integration of AI with real-world evidence and clinical trial modernization will lead to sizable demand in the market.

The report on the global AI in pharma and biotech market covers the following areas:

  • Global AI in pharma and biotech market sizing
  • Global AI in pharma and biotech market forecast
  • Global AI in pharma and biotech market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global AI in pharma and biotech market vendors that include Aria Intelligent Solutions, Arzeda Corp., Atomwise Inc., Auransa Inc., BenevolentAI, BioAge Labs Inc., Cloud Pharmaceuticals Inc., Deep Genomics Inc., Exscientia plc, Healx Ltd., Insilico Medicine, Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Schrodinger Inc., Turbine Ltd., Valo Health, Verge Analytics Inc., Shenzhen Jingtai Technology Co.Ltd. Also, the global AI in pharma and biotech market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

  • 5.1 Global AI In Pharma And Biotech Market 2019 - 2023
    • Historic Market Size - Data Table on Global AI In Pharma And Biotech Market 2019 - 2023 ($ million)
  • 5.2 Type segment analysis 2019 - 2023
    • Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • 5.3 Technology segment analysis 2019 - 2023
    • Historic Market Size - Technology Segment 2019 - 2023 ($ million)
  • 5.4 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Five Forces Analysis

  • 6.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 6.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 6.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 6.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 6.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 6.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 6.7 Market condition

7 Market Segmentation by Type

  • 7.1 Market segments
  • 7.2 Comparison by Type
  • 7.3 Small molecules - Market size and forecast 2024-2029
  • 7.4 Large molecules - Market size and forecast 2024-2029
  • 7.5 Vaccines - Market size and forecast 2024-2029
  • 7.6 Cell and gene therapies - Market size and forecast 2024-2029
  • 7.7 Market opportunity by Type
    • Market opportunity by Type ($ million)

8 Market Segmentation by Technology

  • 8.1 Market segments
  • 8.2 Comparison by Technology
  • 8.3 Machine learning - Market size and forecast 2024-2029
  • 8.4 Deep learning - Market size and forecast 2024-2029
  • 8.5 NLP - Market size and forecast 2024-2029
  • 8.6 Computer vision - Market size and forecast 2024-2029
  • 8.7 Generative AI - Market size and forecast 2024-2029
  • 8.8 Market opportunity by Technology
    • Market opportunity by Technology ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
  • 9.2 Comparison by Application
  • 9.3 Drug discovery - Market size and forecast 2024-2029
  • 9.4 Preclinical and clinical trials - Market size and forecast 2024-2029
  • 9.5 Regulatory compliance and pharmacovigilance - Market size and forecast 2024-2029
  • 9.6 Others - Market size and forecast 2024-2029
  • 9.7 Market opportunity by Application
    • Market opportunity by Application ($ million)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
  • 11.2 Geographic comparison
  • 11.3 North America - Market size and forecast 2024-2029
    • 11.3.1 US - Market size and forecast 2024-2029
    • 11.3.2 Canada - Market size and forecast 2024-2029
    • 11.3.3 Mexico - Market size and forecast 2024-2029
  • 11.4 Europe - Market size and forecast 2024-2029
    • 11.4.1 Germany - Market size and forecast 2024-2029
    • 11.4.2 UK - Market size and forecast 2024-2029
    • 11.4.3 France - Market size and forecast 2024-2029
    • 11.4.4 The Netherlands - Market size and forecast 2024-2029
    • 11.4.5 Italy - Market size and forecast 2024-2029
    • 11.4.6 Spain - Market size and forecast 2024-2029
  • 11.5 APAC - Market size and forecast 2024-2029
    • 11.5.1 China - Market size and forecast 2024-2029
    • 11.5.2 Japan - Market size and forecast 2024-2029
    • 11.5.3 India - Market size and forecast 2024-2029
    • 11.5.4 South Korea - Market size and forecast 2024-2029
    • 11.5.5 Australia - Market size and forecast 2024-2029
    • 11.5.6 Indonesia - Market size and forecast 2024-2029
  • 11.6 South America - Market size and forecast 2024-2029
    • 11.6.1 Brazil - Market size and forecast 2024-2029
    • 11.6.2 Argentina - Market size and forecast 2024-2029
    • 11.6.3 Colombia - Market size and forecast 2024-2029
  • 11.7 Middle East and Africa - Market size and forecast 2024-2029
    • 11.7.1 Saudi Arabia - Market size and forecast 2024-2029
    • 11.7.2 UAE - Market size and forecast 2024-2029
    • 11.7.3 South Africa - Market size and forecast 2024-2029
    • 11.7.4 Turkey - Market size and forecast 2024-2029
    • 11.7.5 Israel - Market size and forecast 2024-2029
  • 11.8 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

12 Drivers, Challenges, and Opportunity

  • 12.1 Market drivers
    • Imperative to overcome declining research and development productivity and escalating costs
    • Exponential growth of biomedical data and availability of high-performance computing
    • Increasing investment, strategic collaborations, and validating success stories
  • 12.2 Market challenges
    • Data quality, accessibility, and governance challenges
    • High cost of implementation and scarcity of specialized talent
    • Regulatory uncertainty and black box problem
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 12.4 Market opportunities
    • Industrialization of discovery through scalable, AI-powered research and development platforms
    • AI-driven biomarker discovery and scaling of precision medicine
    • Increasing integration of AI with real-world evidence and clinical trial modernization

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Company ranking index
    • Company ranking index
  • 14.3 Market positioning of companies
    • Matrix on companies position and classification
  • 14.4 Aria Intelligent Solutions
    • Aria Intelligent Solutions - Overview
    • Aria Intelligent Solutions - Product / Service
    • Aria Intelligent Solutions - Key offerings
    • SWOT
  • 14.5 Auransa Inc.
    • Auransa Inc. - Overview
    • Auransa Inc. - Product / Service
    • Auransa Inc. - Key offerings
    • SWOT
  • 14.6 BenevolentAI
    • BenevolentAI - Overview
    • BenevolentAI - Product / Service
    • BenevolentAI - Key offerings
    • SWOT
  • 14.7 BioAge Labs Inc.
    • BioAge Labs Inc. - Overview
    • BioAge Labs Inc. - Product / Service
    • BioAge Labs Inc. - Key offerings
    • SWOT
  • 14.8 Cloud Pharmaceuticals Inc.
    • Cloud Pharmaceuticals Inc. - Overview
    • Cloud Pharmaceuticals Inc. - Product / Service
    • Cloud Pharmaceuticals Inc. - Key offerings
    • SWOT
  • 14.9 Exscientia plc
    • Exscientia plc - Overview
    • Exscientia plc - Product / Service
    • Exscientia plc - Key offerings
    • SWOT
  • 14.10 Insilico Medicine
    • Insilico Medicine - Overview
    • Insilico Medicine - Product / Service
    • Insilico Medicine - Key offerings
    • SWOT
  • 14.11 Owkin Inc.
    • Owkin Inc. - Overview
    • Owkin Inc. - Product / Service
    • Owkin Inc. - Key offerings
    • SWOT
  • 14.12 PathAI Inc.
    • PathAI Inc. - Overview
    • PathAI Inc. - Product / Service
    • PathAI Inc. - Key offerings
    • SWOT
  • 14.13 Recursion Pharmaceuticals Inc.
    • Recursion Pharmaceuticals Inc. - Overview
    • Recursion Pharmaceuticals Inc. - Product / Service
    • Recursion Pharmaceuticals Inc. - Key offerings
    • SWOT
  • 14.14 Schrodinger Inc.
    • Schrodinger Inc. - Overview
    • Schrodinger Inc. - Business segments
    • Schrodinger Inc. - Key offerings
    • Schrodinger Inc. - Segment focus
    • SWOT
  • 14.15 Turbine Ltd.
    • Turbine Ltd. - Overview
    • Turbine Ltd. - Product / Service
    • Turbine Ltd. - Key offerings
    • SWOT
  • 14.16 Valo Health
    • Valo Health - Overview
    • Valo Health - Product / Service
    • Valo Health - Key offerings
    • SWOT
  • 14.17 Verge Analytics Inc.
    • Verge Analytics Inc. - Overview
    • Verge Analytics Inc. - Product / Service
    • Verge Analytics Inc. - Key offerings
    • SWOT
  • 14.18 Shenzhen Jingtai Technology Co.Ltd
    • Shenzhen Jingtai Technology Co.Ltd - Overview
    • Shenzhen Jingtai Technology Co.Ltd - Product / Service
    • Shenzhen Jingtai Technology Co.Ltd - Key offerings
    • SWOT

15 Appendix

  • 15.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations